, and Extracts of Guava and Mulberry Leaves Present Good Inhibiting Potential on Obesity and Associated Metabolic Disorders in High-fat Diet Obesity Mice Model

Overview

Journal J Tradit Complement Med

Specialty Rehabilitation Medicine

Date 2023 May 2

PMID 37128193

Authors

Pao-Chuan Hsieh

Wu-Yuan Chen

Tzu-Ming Wang

Yung-Lin Chu

Affiliations

Soon will be listed here.

Abstract

This study aimed to investigate the anti-obesity effects of BALASAN (combinational guava leaf extract and mulberry leaf extract), and CC/BALASAN (CC/BAL) on high-fat diet-induced obese C57BL/6 mice and to explore possible mediating mechanisms in 3T3-L1 pre-adipocytes. Oil red-O stain was used to test the effects of CC, BALASAN, and CC/BAL on the differentiation of 3T3-L1 pre-adipocytes. Additionally, real-time PCR was used to detect the expression of genes involved in adipocyte differentiation and inflammation-related genes in adipose tissue of mice that were fed a high-fat diet. CC, BALASAN, and CC/BAL inhibited the differentiation of 3T3-L1 pre-adipocytes and exhibited excellent inhibitory ability against the expression of and genes associated with adipocyte differentiation. Replenishing mice with a high-fat diet with CC, BALASAN, and CC/BAL reduced body weight gaining and blood glucose and plasma cholesterol levels. CC also effectively reduced liver weight, whereas BALASAN and CC/BAL had no inhibitory effect. In addition, CC effectively inhibited the expression of C/EBP-α in adipose tissue. Interestingly, BALASAN not only inhibited the expression of C/EBP-α, but also that of PPARγ, RXRα, and TNFα. Such data indicated that CC, BALASAN, and CC/BAL may have potentially beneficial effects against obesity and associated metabolic disorders by down-regulating the PPARγ/RXRα pathway.

References

Kim J, Kim S, Lee H, Kim I, Ahn M, Ryu K . Determination of 1-deoxynojirimycin in Morus alba L. leaves by derivatization with 9-fluorenylmethyl chloroformate followed by reversed-phase high-performance liquid chromatography. J Chromatogr A. 2003; 1002(1-2):93-9. DOI: 10.1016/s0021-9673(03)00728-3. View

Akduman D, Haksever M, Yanilmaz M, Solmaz F . Mulberry hypertrophy and accompanying sinonasal pathologies: A review of 68 cases. Ear Nose Throat J. 2016; 95(8):E1-7. View

Kiran S, Rakib A, Kodidela S, Kumar S, Singh U . High-Fat Diet-Induced Dysregulation of Immune Cells Correlates with Macrophage Phenotypes and Chronic Inflammation in Adipose Tissue. Cells. 2022; 11(8). PMC: 9031506. DOI: 10.3390/cells11081327. View

Tontonoz P, Hu E, Spiegelman B . Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994; 79(7):1147-56. DOI: 10.1016/0092-8674(94)90006-x. View

Tung Y, Li S, Huang Q, Hung W, Ho C, Wei G . 5-Demethylnobiletin and 5-Acetoxy-6,7,8,3',4'-pentamethoxyflavone Suppress Lipid Accumulation by Activating the LKB1-AMPK Pathway in 3T3-L1 Preadipocytes and High Fat Diet-Fed C57BL/6 Mice. J Agric Food Chem. 2016; 64(16):3196-205. DOI: 10.1021/acs.jafc.6b00706. View

Colon-Mesa I, Fernandez-Galilea M, Sainz N, Lopez-Yus M, Artigas J, Arbones-Mainar J . Regulation of p27 and Cdk2 Expression in Different Adipose Tissue Depots in Aging and Obesity. Int J Mol Sci. 2021; 22(21). PMC: 8584112. DOI: 10.3390/ijms222111745. View

Makki K, Froguel P, Wolowczuk I . Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2014; 2013:139239. PMC: 3881510. DOI: 10.1155/2013/139239. View

Matthews V, Allen T, Risis S, Chan M, Henstridge D, Watson N . Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia. 2010; 53(11):2431-41. DOI: 10.1007/s00125-010-1865-y. View

Dasari V, Kaur K, Velpula K, Gujrati M, Fassett D, Klopfenstein J . Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. PLoS One. 2010; 5(4):e10350. PMC: 2859936. DOI: 10.1371/journal.pone.0010350. View

10.

Osborn O, Brownell S, Sanchez-Alavez M, Salomon D, Gram H, Bartfai T . Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. Cytokine. 2008; 44(1):141-8. PMC: 3063393. DOI: 10.1016/j.cyto.2008.07.004. View

11.

Kim J, Lee S, Kang Y, Kwon T, Nam J . Kahweol inhibits adipogenesis of 3T3-L1 adipocytes through downregulation of PPARγ. Nat Prod Res. 2017; 32(10):1216-1219. DOI: 10.1080/14786419.2017.1326039. View

12.

Zatterale F, Longo M, Naderi J, Raciti G, Desiderio A, Miele C . Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol. 2020; 10:1607. PMC: 7000657. DOI: 10.3389/fphys.2019.01607. View

13.

Akagiri S, Naito Y, Ichikawa H, Mizushima K, Takagi T, Handa O . A Mouse Model of Metabolic Syndrome; Increase in Visceral Adipose Tissue Precedes the Development of Fatty Liver and Insulin Resistance in High-Fat Diet-Fed Male KK/Ta Mice. J Clin Biochem Nutr. 2008; 42(2):150-7. PMC: 2266061. DOI: 10.3164/jcbn.2008022. View

14.

Farmer S . Transcriptional control of adipocyte formation. Cell Metab. 2006; 4(4):263-73. PMC: 1958996. DOI: 10.1016/j.cmet.2006.07.001. View

15.

Harano Y, Yasui K, Toyama T, Nakajima T, Mitsuyoshi H, Mimani M . Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. Liver Int. 2006; 26(5):613-20. DOI: 10.1111/j.1478-3231.2006.01265.x. View

16.

McArdle M, Finucane O, Connaughton R, McMorrow A, Roche H . Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies. Front Endocrinol (Lausanne). 2013; 4:52. PMC: 3650620. DOI: 10.3389/fendo.2013.00052. View

17.

Yamato M, Shiba T, Ide T, Seri N, Kudo W, Ando M . High-fat diet-induced obesity and insulin resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice. Mol Cell Biochem. 2011; 359(1-2):161-7. DOI: 10.1007/s11010-011-1010-3. View

18.

Handa M, Vanegas S, Maddux B, Mendoza N, Zhu S, Goldfine I . XOMA 052, an anti-IL-1β monoclonal antibody, prevents IL-1β-mediated insulin resistance in 3T3-L1 adipocytes. Obesity (Silver Spring). 2013; 21(2):306-9. DOI: 10.1002/oby.20004. View

19.

Chung J, Nguyen A, Henstridge D, Holmes A, Chan M, Mesa J . HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A. 2008; 105(5):1739-44. PMC: 2234214. DOI: 10.1073/pnas.0705799105. View

20.

Xie W, Zhang Y, Wang N, Zhou H, Du L, Ma X . Novel effects of macrostemonoside A, a compound from Allium macrostemon Bung, on hyperglycemia, hyperlipidemia, and visceral obesity in high-fat diet-fed C57BL/6 mice. Eur J Pharmacol. 2008; 599(1-3):159-65. DOI: 10.1016/j.ejphar.2008.09.042. View